Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of lung
|
1142 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Endometrial Neoplasms
|
32 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Inflammatory Bowel Diseases
|
605 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of endometrium
|
197 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Autoimmune Chronic Hepatitis
|
23 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.720 | 1.000 | 2 | 2014 | 2017 | |||||
Autoimmune hepatitis
|
22 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Autoimmune Hepatitis with Centrilobular Necrosis
|
3 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||
Coronary Artery Disease
|
1577 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.810 | 1.000 | 5 | 2013 | 2018 | |||||
Cholangitis, Sclerosing
|
276 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 3 | 2013 | 2017 | |||||
Antiphospholipid Syndrome
|
17 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Arthritis, Gouty
|
2356 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Beta-2-microglobulin measurement
|
7 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||
Gout
|
2354 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Primary sclerosing cholangitis
|
58 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Tetralogy of Fallot
|
83 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Hemoglobin measurement
|
224 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 3 | 2012 | 2017 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 3 | 2012 | 2018 | |||||
Serum total cholesterol measurement
|
1243 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 3 | 2012 | 2018 | |||||
Hypothyroidism
|
283 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 2 | 2012 | 2019 | |||||
Serum LDL cholesterol measurement
|
555 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 2 | 2012 | 2013 | |||||
Corpuscular Hemoglobin Concentration Mean
|
4389 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Primary biliary cirrhosis
|
667 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2012 | 2012 |